KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Equity Income: 2021-2025

Historic Equity Income for Thermo Fisher Scientific (TMO) over the last 4 years, with Sep 2025 value amounting to $2.0 million.

  • Thermo Fisher Scientific's Equity Income rose 114.29% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $23.0 million, marking a year-over-year increase of 130.26%. This contributed to the annual value of -$42.0 million for FY2024, which is 28.81% up from last year.
  • Latest data reveals that Thermo Fisher Scientific reported Equity Income of $2.0 million as of Q3 2025, which was down 0.00% from $2.0 million recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year Equity Income high stood at $33.0 million for Q4 2024, and its period low was -$84.0 million during Q2 2024.
  • For the 3-year period, Thermo Fisher Scientific's Equity Income averaged around -$10.1 million, with its median value being -$14.0 million (2025).
  • In the last 5 years, Thermo Fisher Scientific's Equity Income tumbled by 5,000.00% in 2022 and then skyrocketed by 3,400.00% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Equity Income (Quarterly) stood at -$3.0 million in 2021, then tumbled by 2,300.00% to -$30.0 million in 2022, then skyrocketed by 96.67% to -$1.0 million in 2023, then spiked by 3,400.00% to $33.0 million in 2024, then surged by 114.29% to $2.0 million in 2025.
  • Its Equity Income stands at $2.0 million for Q3 2025, versus $2.0 million for Q2 2025 and -$14.0 million for Q1 2025.